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Northern Ireland Surgical Registrars' Prize Meeting
The first Northern Ireland Surgical Registrars'
Prize Meeting was held in the Royal Victoria
Hospital on Friday, 10th November 2000. All
Basic and Higher Surgical Trainees within the
Northern Ireland SurgicalTraining Schemes had
beeninvitedtosubmitabstracts forconsideration
forpresentationatthemeeting.Fromasubmission
of 26 abstracts, ten papers were selected for
presentation.
Followingthemeeting,theJohnTempletonPrize
for the outstanding presentation was awarded to
Mr. Kevin McCallion for his paper entitled
"Neurosurgical patients admitted to Intensive
Care Units exhibit a systemic inflammatory
response which is distinct from the mixed
antagonist response syndrome exhibited by
emergency surgical/trauma patients". Two
additional prizes, the Ethicon and the Janssen
Cilag awards, were given to Miss Jan Bingham
and Mr. Robert Kennedy for their respective
papers.
Thefollowing tenabstracts werepresentedatthe
meeting:
AN EVALUATION OF SERIAL MEASUREMENTS
OF CEA AND CA 15-3 IN THE DETECTION OF
PRE-CLINICAL RECURRENCE IN BREAST
CANCER
L J Fon, B Cartmill, M Stokes
DepartmentofSurgery, DaisyHillHospital,Newry, BT35
8DR, Northern Ireland.
INTRODUCTION
Anelevationintheleveloftumourmarkers, CEA
and CA 15-3, in blood has been positively
correlatedwiththeclinicalstageofbreastcancer.
However, their use in the monitoring of disease
recurrenceremainsunclearintheclinicalsetting.
CombiningtheuseofCEAandCA 15-3 hasbeen
reported to have a 64%-94% sensitivity for
detecting disease recurrence, and a normal level
suggests an absence of metastatic disease.
However the specificity ofthese human markers
and the senior level above which they are
indicative of disease recurrence remains to be
elucidated.
AIM
We aim to determine the sensitivity and
specificity, and the role of serial measurements
of CEA and ca 15-3 in the detection of early
recurrences in breast cancer, prior to the
development of clinical signs or symptoms.
METHODS
Sequential measurements of CEA and Ca 15-3
were performed in the follow-up blood samples
of 115 breast cancer patients who presented
between 1995 to 2000, after treatment for their
primary disease. The levels of these tumour
markers were correlated with the clinical data.
Thecut-offvalues forserumCEAwas compared
between 2 ng/ml and 4 ng/ml, and for CA 15-3
was at 25 U/ml.
RESULTS
Duringfollow-up,28patients(24.3%)developed
recurrent disease. The sensitivity of serum CEA
for detecting recurrent breast cancer was 37%
(10/27), and specificity 83% using acutofflevel
>4 ng/ml. The sensitivity increased to 66% (18/
27) whenaCEAcut-offlevel>2ng/mlwasused,
butthe specificity dropped to 50%. ForCA 15-3,
the sensitivity was 57.7% and specificity also
83%. Combining both CEA (cut-off2 ng/ml and
4 ng/ml) and CA 15-3, the sensitivity was found
tobe69.2% and84.6%, andthespecificity65.9%
and 36.4% respectively.
The CEA and CA 15-3 levels were raised in
69.2% (18/26) using CEA >4 ng/ml as cut-off:
they wereraised in 88.5% (22/26) using CEA >2
ng/ml as cut-off. The time between a rise in the
serum level of these tumour markers and the
appearance of clinically detectable disease was
between 2 to 44 months. Six patients developed
symptomatic disease recurrence. They were
further investigated radiologically, resulting in
theadministration ofadifferentadjuvanttherapy
in S patients.
CONCLUSION
Combining the use of 2 tumour markers, CEA
and.CA 15-3, enabled early detection of breast
cancer recurrence prior to the development of
clinically apparent disease. A high sensitivity
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and specificity was achieved using CEA >4 ng/
ml and CA 15-3 >25 U/ml to indicate disease
recurrence. Weproposethatserialmeasurements
ofCEAandCa 15-3 maybeincorporatedintothe
routine follow-up assessment of breast cancer
patients.
THE USE OF URINARY TNF RECEPTOR
CONCENTRATION AS AN INFLAMMATORY
MARKER AND DIAGNOSTIC TOOL IN
GASTROINTESTINAL DISEASE
R J Kennedy, M McCaigue,* S J Kirk,* K R
Gardiner.
Colorectal SurgeryUnit&DepartmentofSurgery,* Royal
Victoria Hospital, Belfast.
Soluble tumournecrosis factorreceptors (TNFr)
are released in sepsis. Urinary concentrations of
TNFr have been shown to correlate with disease
activityinpatientswithIBD.Inthisstudy,urinary
concentrations of TNFr were measured along
with recognised markers of inflammation in
patients with one of four gastrointestinal
conditions [colorectal carcinoma, acute
diverticulitis, ulcerativecolitis(UC)andCrohn's
disease (CD)] and in healthy controls. We
hypothesised firstly that urinary TNFr
concentrationwouldcorrelatewithothermarkers
of inflammation in gastrointestinal disease and
secondly that TNFr measurement might be used
to differentiate between UC and CD.
METHODS
Forty patients were recruited to the trial. Ten
healthy controls were also enrolled. Erythrocyte
sedimentationrate (ESR), C-reactiveprotein and
alpha-I acid glycoprotein were measured using
standard laboratory techniques. Urine was also
collected for measurement of p75 TNFr
concentrations. Spearman's rank coefficients
were used to assess correlation. The Mann-
Whitney U test compared the ulcerative colitis
and Crohn's disease results.
UrinaryTNFrconcentrationscorrelatedpositively
with each ofthe other markers in each condition
(P<0.001). There was no significant difference
between TNFr concentrations in UC and CD
(P=0.257).
The non-invasive measurement ofurinary TNFr
concentration may, in the future, be a useful,
cost-effectivemarkerofinflammationinpatients
withgastrointestinal inflammationbutisunlikely
to differentiate between ulcerative colitis and
Crohn's disease.
RESULTS ARE EXPRESSED AS MEDIAN (INTER-QUARTILE RANGE)
n= ESR C-reactive a-l acid Urinary TNFr
(mmn/hr) protein glycoprotein (ng/ml)
(ingiL) (giL)
Colonic carcinoma 10 43(30-98) 48(38-242) 1.9(1.3-2.2) 22.8 (5.1-31.7)
Acute diverticulitis 10 79(46-111) 53(9-79) 2.0(1.1-2.1) 30.8(21.1-60.3)
Ulcerative colitis 10 15(12-26) 3(0-10) 1.0(0.6-1.2) 8.3(4.2-10.6)
Crohn's disease 10 25(16-50) 8(3-28) 1.6(1.2-2.6) 9.9(7.9-12.4)
Controls 10 14(13-19) 0(0-0) 0.5(0.3-0.6) 3.7(3.0-5.2)
NEUROSURGICAL PATIENTS (NSX) ADMITTED
TO INTENSIVE CARE UNITS (ICU) EXHIBIT A
SYSTEMIC INFLAMMATORY RESPONSE
WHICH IS DISTINCT FROM THE MIXED
ANTAGONIST RESPONSE SYNDROME (MARS)
EXHIBITED BY EMERGENCY SURGICAL/
TRAUMA PATIENTS (TSX)
K McCallion, D F McAuleyt, D W Harkin, G E
Brown*, P J Erwin, G Laveryt, M I Halliday, K
R Gardiner.
Depts of Surgery, Queen's University of Belfast, Belfast
& *Beth Israel Deaconess Medical Center, Boston, USA.
tIntensive Care Unit, Royal Victoria Hospital, Belfast.
INTRODUCTION
It was hypothesised that NSx patients requiring
ICU admission would exhibit evidence of a
systemicinflammatoryresponse,explainingtheir
risk ofmulti-organ dysfunction.
METHOD
NSx (elective and emergency, n=15) and TSx
(n=10) patients admitted to a regional ICU had
blood taken on the 3rd day of admission. Blood
was also taken from controls (n=24). Maximal
neutrophil (PMN) respiratory burst activity was
assayed over 17.3 mins using a BioOrbit 1251
Luminometer to detect whole blood
chemiluminescence in the presence of luminol,
phorbol 1,2- myristate 1,3-acetate and tumour
necrosisfactor. Thepeaksignalwasobtainedand
divided by the white cell count (xlO -7mV/white
cell). Soluble p55 TNF receptor (anti-
inflammatory marker) and interleukin 6 (IL6,
pro-inflammatory marker) were measured by
ELISA and bioassay respectively.
RESULTS (MEDIAN [Q1,Q3])
TSx patients exhibited a MARS on day 3, with
elevatedIL6(547 [232,720]pg/mlvsundetectable
levels in controls, p<0.001), elevated p55TNF
(22 [15, 36] ng/ml vs 8 [5, 13] ng/ml in controls,
p=O.OO7) and elevated PMN activity (61 [26,94]
vs 14 [11,19] incontrols, p=O.OOl). NSxpatients
exhibited a different inflammatory pattern, with
C) The Ulster Medical Society, 2001.74 The UlsterMedical Journal
elevatedIL6(217 [48,280] pg/mlvsundetectable
levelsincontrols,p=0.030), noriseinp55TNF(9
[7, 13] ng/ml vs 8 [5, 13] ng/ml in controls,
p=0.662) andanon-significant elevationinPMN
activity (30 [7, 79] vs 14 [11, 19] in controls,
p=O.107).
DISCUSSION
The concept ofa balance between pro- and anti-
inflammatory mediators is attractive, explaining
why measurements of a single mediator may be
misleading. As PMN are subject to stimulation
by many such mediators, assays of respiratory
burst activity may be useful in determining the
status of such a balance.
CONCLUSION
Patients admitted to ICU with neurosurgical
insults exhibitasystemic inflammatoryresponse
whichisdistinctfromthatexhibitedbyemergency
surgical/trauma patients.
EUROPEAN QUESTIONNAIRE SURVEY OF
SURGICAL STRATEGIES FOR THE
MANAGEMENT OF SEVERE ACUTE
PANCREATITIS.
Beattie G C, Saharia R, Parks R W, Powell J J,
Siriwardena A K*.
Department of Surgery and Clinical Sciences, Royal
Infirmary of Edinburgh and Department of Surgery,
Manchester Royal Infirmary, Manchester, UK.
OBJECTIVES
Although contemporary guidelines provide a
framework for the initial management of severe
acute pancreatitis, there remains no consensus
opinionregarding the optimal surgical strategies
for local complications. The objective of this
study was to survey surgeons in hepatobiliary
units across Europe to establish an overview of
the current surgical management ofsevere acute
pancreatitis.
METHODS
A mailshot questionnaire survey was sent to 866
members of the European Chapter of the
InternationalHepatobiliaryAssociation(IHPBA).
A total of 331 questionnaires were returned, but
only 327 (38%) were suitable for analysis (4
clinicians retired).
RESULTS
The most common (127 [38.8%]) number of
patients with severeacutepancreatitis treatedper
year was 11 to 20. The commonest severity
stratification system used was Ranson's criteria
(168 [51.4%]). CRP was used as a serum marker
of disease severity by 149 (45%) respondents,
however 180 [55%] respondents used clinical
assessment also. Prophylactic antibiotic therapy
in severe acute pancreatitis was used by 229
(70%) ofrespondents, thecommonestantibiotics
used being third generation cephalosporins and
imipenem. The majority of respondents (210
[64.2%]) usedanearly (within72hours)CTwith
284 (86.9%) using intravenous contrast. 168
(51.4%) respondents use FNA of pancreatic
necrosis forthediagnosis oflocalinfection, with
99 (30.3%) of these stating they would always
operate on apositive FNA. There was no general
consensus as to the optimal timing of surgical
intervention. The commonest procedure carried
out for pancreatic abscess was percutaneous
drainage ( 154 [47. 1 %]). The commonest
procedureperformedforpancreatic necrosis was
surgical drainage, followed by closed irrigation
(142 [43.4%]), then staged surgical resection
(necrosectomy with skin closure andplannedre-
operation) in 94 (28.7%) respondents.
CONCLUSIONS
This study highlights the widely disparate
protocolscurrentlyemployedinthemanagement
of severe acute pancreatitis, advocating the
implementation of standardised guidelines to
encourage more consistency in the management
of severe acute pancreatitis.
CIRCULATING LEVELS OF VASCULAR
ENDOTHELIAL GROWTH FACTOR
FOLLOWING OESOPHAGEAL CANCER
RESECTION - RELATIONSHIP TO PLATELET
COUNT
G M Spence*, A N J Graham*, K. Mulhollandt,
IMcAllister*, KGMcManus*, PMaxwellt, JM
Sloant, MAArmstrong§, FCCampbell: andJA
McGuigan*.
DepartmentofThoracicSurgery*,RoyalVictoriaHospital,
Belfast, Departments of Pathologyt, Surgeryt &
Microbiology/Immunobiology§, Queen's University,
Belfast, BT12 6BJ.
BACKGROUND
It has been proposed that serum (S-VEGF) or
plasma (P-VEGF) Vascular Endothelial Growth
Factorlevelsmayhaveprognostic significancein
patients followingcancerresection. Howeverthe
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potentialconfoundingeffectofsurgicaltraumais
unknownTheaimofthis studywastoinvestigate
thedegreeanddurationofalterationincirculating
VEGFconcentrationandplateletcountfollowing
oesophageal cancer resection.
METHODS
S-VEGF, P-VEGF and platelet counts were
measured in 23 patients undergoing oesophageal
cancer resection. Samples were taken
preoperatively and at6weeks following surgery.
Sevenpatientswerealsosampledonpostoperative
days 1,5 and 10.VEGFlevelswereassayedusing
an Enzyme Linked Immunosorbent Assay
(ELISA) kit specific for Human VEGF
(Quantikine human VEGF, R&D Systems,
Minneapolis, Minnesota.).
RESULTS
Circulating levels of VEGF were elevated
postoperatively. However by 6 weeks S-VEGF
had fallen to baseline but P-VEGF remained
elevated (p<0.05, Wilcoxon Signed Ranks).
Platelet counts mirrored changes in circulating
VEGF levels, correlating closely with S-VEGF
(rho=0.281; p<0.05, Spearman's Rank) and P-
VEGF (rho=0.330; p<0.01, Spearman's Rank).
CONCLUSIONS
Surgery causes comparable elevations inplatelet
count and circulating VEGF postoperatively. S-
VEGF and P-VEGF are closely associated with
platelet count. The prognostic significance of
circulating VEGF independent ofplatelet count
remains to be confirmed.
RECURRENT SYMPTOMS AND FAECAL
INCONTINENCE FOLLOWING
HAEMORRHOIDECTOMY
YousafM, Abdalla R, Gilliland R.
Altnagelvin Area Hospital, Londonderry.
INTRODUCTION
Haemorrhoidectomy has been the gold standard
forthe treatment ofsignificant haemorrhoids for
manyyears. Howeverthelong-termoutcomeand
the incidence of faecal incontinence following
surgery is largely unquantified.
METHODS
The case notes of all patients who underwent a
haemorrhoidectomyfromJanuary 1988toJanuary
1999werereviewed. Demographic andoperative
data were retrieved. All patients were sent a
postal questionnaire concerning recurrent
symptoms, faecal incontinence, GP attendance
and overall satisfaction.
RESULTS
164 patients (81 male; 83 female) received a
questionnaire of which 120 (73.2%) responded.
Three patients were deceased, 1 had apermanent
ileostomy, and 40 were lost to follow up. The
majority had elective surgery (n=112). The
median age at the tine of surgery was 53 years
(44-63) years and the median follow-up was 70
months (45-95).
Chart review suggested that 92 (76.5%) patients
had not incurred a complication. Only 5 (4.2%)
patients were recorded as having any degree of
faecal incontinence post-operatively.
Questionnaire results showed that 44 (36.7%)
patients were symptom free whereas 28 (23.3%)
patients had symptoms more than once/week.
Twenty eight (23.3%) patients had consulted
theirGPand30(25%)hadusedfurthertreatment.
Bleeding was better controlled than itch/
discomfort (nobleeding =73; noitch/discomfort
= 59). Only 45 (37.5%) patients werecompletely
continent with 9 (7.5%) patients complaining of
incontinenceofsolids,liquids, andgasmorethan
once/week. A significantly higher proportion of
patients who had undergone anal stretch at the
timeofsurgery (n=29)experiencedincontinence
compared with those who did not have this
additional procedure (69% vs 61%; p=0.05)*.
Overall patient satisfaction was high with 91
(75.8%) grading their outcome as excellent or
good.
CONCLUSIONS
Although surgery is considered as the definitive
treatmentforhaemorrhoids, asignificantnumber
of patients have recurrent symptoms or faecal
incontinence, which they may not report. Anal
stretch at the time of surgery results in a higher
incidence of faecal incontinence.
* Fisher's exact
CAN POOR OUTCOME AFTER CARDIAC
SURGERY BE PREDICTED?
Quality oflifeand survival inpatients after along stay
in cardiac surgical ICU following cardiac surgery
P Bonde, A Robb, H O'Kane, D Gladstone, G
Campalani, M Sarsam, S MacUowan.
Royal Victoria Hospital, Department of Cardiac Surgery,
Grosevenor Road, Belfast BT12 6BA.
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Long stay in the ICU following cardiac surgery
has major implications regarding manpower and
resource utilisation. Majority ofcardiac surgical
procedures have a low risk with highprobability
ofreliefofsymptoms and improved expectation
ofqualityoflife.Apredictivemodelthatidentified
patients who are certain to die would spare
suffering and free resources. The aim of this
study was to check the accuracy of the current
risk scoring algorithms available to the clinician
inpredicting-pooroutcomeaftercardiacsurgery.
In the calendar year 1998, 1,006 adult patients
underwent cardiac surgical procedures, only 34
(3.37%) spent more than 96 hours in the cardiac
surgicalICU,theaveragelengthofstayexcluding
the long staypatients was 24hours. Patients who
had aprotracted stay themean was 631 hours (26
days),range(96-2,158hours). Datawascollected
onthese 34 longstaypatientsretrospectively and
preoperative estimation of Parsonnet and
Euroscore was done, postoperative estimation of
APACHE II score and mortality prediction was
performed. In hospital mortality in this group
was 26.47% (9 deaths). Attheendofoneandhalf
years there were 23 survivors, (11 deaths),
telephonic administration ofquality oflife Short
Form (SF 36v2TM) questionnaire was done, 20
patientsansweredthequestionnaire, twopatients
could not be traced while one refused to answer.
The sensitivity andspecificity was calculatedfor
the preoperative risk scores and postoperative
APACHE II score for mortality prediction.
Parsonnet score had (sensitivity=0.20,
specificity=0.95, overall accuracy=0.72),
Euroscore (sensitivity=0.45, specificity=0.91,
overall accuracy=0.76), APACHE II score at 32
hourspostop(sensitivity=0.82, specificity=0.76,
overall accuracy=0.78), the predicted death rate
calculated from APACHE II score
(sensitivity=0.82, specificity=0.83, overall
accuracy=0.82). Quality of life was severely
affectedwithphysicalstatusscoreof39.08 (range
22.21-57.09), howeverthe average mental status
score of50.034 (range 22.75-63.31) represented
only mild affection. The maximum number of
potential ICU beds that could be freed was 61
days (16.71%).
Poor outcome after cardiac surgery can be
predicted. The existing preoperative risk scores
work well for the low risk patients but their
accuracy is less inhighriskpatients. APACHE II
score is designed for the noncardiac surgical
patients, but it works well in high-risk cardiac
surgicalpatients. Thequalityoflifeissignificantly
affected in the long stay patients after cardiac
surgery. An improved risk algorithm needs to be
developed which takes in to account the
preoperative, intra operative and post operative
factorsindeterminingthemorbidityandmortality
after cardiac surgery.
BILIARY SYSTEM COMPLICATIONS
FOLLOWING LAPAROSCOPIC
CHOLECYSTECTOMY - IMPROVED OUTCOME
WITH EARLY REFERRAL
JBingham,LDMcKie,JMcLoughlin,TDiamond
The Mater Hospital, Crumlin Road, Belfast, Northern
Ireland.
Laparoscopic cholecystectomy is now widely
accepted as the 'gold standard' for treatment of
symptomatic gallstones, however concerns
remain about the incidence of bile duct injury.
We review a series of patients referred to a
hepatobiliary unit with biliary complications
following laparoscopic cholecystectomy.
32 patients were referred over a 7-year period
with complications following laparoscopic
cholecystectomy, 5 male and 27 female with a
median age of 58. Injuries were categorised
according to Strasberg's classification.'
7 patients were referred immediately, 19 early
(within 6 weeks) and 6 late (after 6 weeks). 12
patients sustained 'minor' bile ductinjury (types
A, B andC), 19receiving moremajortype D and
E injuries. 87% of patients required surgical
intervention for definitive management. There
were2deaths and28 oftheremaining30patients
have normal liver function tests at follow-up.
STRASBERG CLASSIFICATION OF BILIARY INJURIES
Type Description No.
Patients
A Injury to bile duct (in continuity with 8
CBD)
B Partial occlusion ofbiliary tree 1
C Injury to bile duct (not in continuity 3
with CBD)
D Laceration to extra-hepatic biliary tree 9
E2 Occlusion ofbiliary tree <2 cm from 10
conflucence
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A successful outcome can be obtained for the
majorityofpatientswhosustainbiliaryinjuriesif
they are promptly referred to a specialist centre.
Latereferralandpreviousinappropriate attempts
at management can be fatal.
LAPAROSCOPY IN THE STAGING OF UPPER
GASTROINTESTINAL MALIGNANCY
M A Taylor, R T Skelly, W D B Clements, M C
Regan
Department of Upper Gastrointestinal and Hepatobiliary
Surgery, The Royal Victoria Hospital, Belfast BT12 6BJ.
BACKGROUND
Optimal management of cancer of the upper
gastrointestinal tract requires accurate pre-
operative staging to facilitate multimodality
therapyplanningandtoidentifythosewhowould
benefitfrompotentiallycurativesurgery. Studies
have suggested that staging laparoscopy is a
usefuladjunctinthisprocess,reducingthenumber
of unnecessary laparotomies in patients with
advanced disease. The aim of this retrospective
study was to compare staging laparoscopy with
CTscanninginthepreoperativestagingofpatients
with upper gastrointestinal malignancy in the
Royal Victoria Hospital over the last 2 years.
METHODS
Since 1998 laparoscopy has been used in
combination with CT scanning in the staging of
patients with upper gastrointestinal malignancy
inthishospital. Themedicalchartsof49patients
inwhichstaginglaparoscopywasperformedwere
reviewed retrospectively.
RESULTS
Over the study period staging laparoscopy was
performed in 33 patients with gastric carcinoma,
10 with pancreatic/periampullary carcinoma, 3
with carcinoid, 1 with a gastrinoma and 2 with
benign disease. Compared with CT scanning,
laparoscopy confirmed ascites in 11 patients
compared to 4. Five patients had peritoneal
involvement that was not identified on CT.
Furthermore; CT scanning suggested liver
metastases in 2 patients that were not confirmed
bylaparoscopy.Inadditionlaparoscopyidentified
a further 2 cases of liver metastases, which the
CT scan had not picked up. There was no
differenceintheobservationoflymphadenopathy
or mass detection using the two modalities.
Cytology ofperitoneal washings at laparoscopy
confirmed malignancy in 6 patients who had
features of advanced disease.
CONCLUSIONS
This small study has demonstrated staging
laparoscopy to be an important adjunct in the
stagingofuppergastrointestinal malignancy asit
identified advanced disease that CT failed to
demonstrate. This reduces the morbidity and
mortality in patients who would formerly have
had an unnecessary laparotomy. Peritoneal
washout cytology does not appear to contribute
significantlytothepre-operative stagingofthese
patients.
ISCHAEMIA REPERFUSION INJURY IS
EXAGGERATED BY DIABETES
W K Edrees, S E Refsum, I S Young, B J
Rowlands, C V Soong
Thisstudyinvestigateswhetherdiabetesmellitus
accentuates hind limb ischaemia reperfusion
injury and leads to greater muscle injury.
METHOD
Male Wistar rats rendered diabetic (n=40)
following injection of streptozotocin were
compared to non-diabetic control rats (n=30).
Each group was divided into sham, 4h of hind
limb ischaemia, 4h ofischaemia followed by 10
min, 30 min or60 min ofreperfusion. Blood was
takenfromtheinferiorvenacavaformeasurement
of plasma concentration of the end product of
lipidperoxidation(malondialdehyde(MDA))and
antioxidants vitamins A & E. Transmembrane
potential (TMP) ofthe gastrocnemius muscle of
the ischaemic limb was also measured.
RESULTS
Mean (s.e.m.)
CONTROL
sham ischaemia 10 min rep. 30 min rep. 60 min rep.
MDA (umolf) 1.4(0.1) 1.1(0.1) 1.6(0.1)* 2.0(0.2)* 1.4(0.1)
Vit.A(umoII1) 1.5(0.1) 1.5(0.1) 1.5 1.4 1.3*
Vit.E(umoII1) 28.0(0.7) 28.0(0.9) 27.4(0.8) 25.4(1.0) 24.9(1.0)*
TMP (mV) 79.0(1.9) 63.0(2.2) 58.2(1.6) 53.5(2.6) 62 2(2.9)
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DIABETIC
sham ischaemia 10 min rep. 30min rep. 60min rep.
MDA 4.6(0.3)t 2.2(0.4)t 3.0(0.3)t 4.3(0.4)t 2.4(0.2)*t
Vit.A LOt 0.9t 0.8*t 0.7*t 07*t
Vit.E 26.9(0.8) 27.9(0.8) 27.7(1.5) 24.1(1.1)* 21.9(0.9)*
TMP 74.4(3.4) 56.0(2.2) 51.5(0.8)t 46.4(1.4)* 57.3(3.0)
* p < 0.05 vs ischaemia, tp < 0.05 vs control
CONCLUSION
These results indicate that oxidative stress
following reperfusion injury is greater in the
presenceofdiabetesmellitus.Thismayinfluence
therecovery ofdiabeticpatients following lower
limb bypass surgery.
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